- Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia. Attar, E.C., De Angelo, D.J., Supko, J.G., D'Amato, F., Zahrieh, D., Sirulnik, A., Wadleigh, M., Ballen, K.K., McAfee, S., Miller, K.B., Levine, J., Galinsky, I., Trehu, E.G., Schenkein, D., Neuberg, D., Stone, R.M., Amrein, P.C. Clin. Cancer Res. (2008)